InMed Pharmaceuticals Inc.
INMNasdaqCIK 1728328HealthcareFiscal year ends Jun 30
All transactions: 1
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-23 | ADAR1 Capital Management, LLC10% owner | Purchase | 4 | $1.32 | $5.28 | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.